Exendin-4 CAS 141758-74-9 Exenatide Acetate Munyu Exenatide
Ndibate:
Email : salesperson66@yeah.net
whatsapp: +8619832408762
wickr: fairyqf
Skype:+8619832408762
Hunhu:
Common name | Exenatide | Zita rechirungu | Exenatide acetate munyu |
---|---|---|---|
CAS nhamba | 141758-74-9 |
Molecular formula | C184H282N50O60S |
---|---|
Molecular uremu | 4186.57000 |
Misa yakarurama | 4184.03000 |
PSA | 1775.05000 |
Kuchengetedza mamiriro | Yakavharwa, chengetedza pa -20ºC |
Kugadzikana | Hapana kuora, hapana maitiro ane ngozi anozivikanwa kana akashandiswa uye akachengetwa zvinoenderana nezvinodiwa |
Kushandisa:
Exenatide ndiyo yekutanga mushonga mukirasi nyowani yeanti-diabetes inozivikanwa se incretin mimetics, uye inoratidzwa seadjunctive therapy yekuvandudza glycemic control kune varwere vane Type 2 chirwere cheshuga vari kutora metformin, sulfonylurea, kana zvese zviri zviviri, asi vasina. akawana zvakakwana glycemic control.Exenatide inoshanda analog yemunhu incretin Glucagon-Senge Peptide-1 (GLP-1).GLP-1 inongoburitswa kubva mumasero ari muGI turakiti mukupindura kudyiwa kwechikafu uye inobata pane yayo receptor pa-b-masero kuti igone kuita glucose-inosimudzira insulin secretion.Exenatide inguva yakareba inobata agonist paGLP-1 receptor.Iyo ishanduro yakagadzirwa ye39-amino acid peptide inowanikwa mumate secretions eGila monster lizard.inogadzirisawo peak serum glucagon mazinga panguva dze hyperglycemic nguva dzinotevera kudya, asi hazvikanganise kuburitswa kweglucagon mukupindura hypoglycemia.Iyo dosing regimen ye exenatide ndeye 5 kana 10 mg kaviri zuva nezuva, inopihwa senge subcutaneous jekiseni mukati meawa pamberi pekudya kwemangwanani nemanheru.Kutevera subcutaneous administration, peak plasma concentrations of exenatide inosvika mumaawa 2.1, uye plasma pharmacokinetic profile inofananidzwa nedosi.Zviitiko zvinonyanya kuipa zvinoshumwa ne exenatide zvinosanganisira kusvotwa, kurutsa, manyoka, kunzwa jittery, dzungu, musoro, uye dyspepsia.
Exendin-4 inogona kumisa iyo GLP-1 receptor, iyo receptor inogona kuwedzera cAMP mazinga epancreatic acinar masero mune intracellular, asi haina mhedzisiro paVIP receptor.
Exendin-4 yakashandiswa se incretin mimetics yekurapa muHepG2 maseru kusabvisa pesvedzero yezvinhu zvekubatsira.Yakashandiswawo se r (GLP-1R) agonist kusabvisa kupindira kubva kune zvekubatsira zvinhu.